COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial
Socioeconomic status tied to multisystem inflammatory syndrome in children
19 February 20213-month interval between first, second dose of Oxford vaccine results in higher vaccine efficacy than 6-week interval
19 February 2021COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial
The Altimmune Inc. vaccine candidate that was tested preclinically at the University of Alabama at Birmingham last year is expected to start patient enrollment for its Phase 1 clinical trial next week.
